DIAH

DIAH 2026

19 – 21 May 2026 | Bruges, Belgium

Christine Labeur

Head of Development

272BIO Limited

Gent, Belgium

24 profile visitsCompanies/Industry

Heading development activities for 272BIO including CMC and bio-analytical activities

My organisation

272BIO Limited

272BIO Limited

Reading, United Kingdom

272BIO is a UK-Belgium based antibody discovery and development company with full in-house CMC process development capability. The company is focused and has a track-record of developing differentiated products with a competitive advantage for indications and opportunities across animal health
Read more

About me

Since 2019 the 272BIO team has established an expert CMC and development team and laboratories in Flanders , Belgium. The team delivers all activities required across the value chain and has delivered materials and bio-analytical tools for several successful POC studies in various species (pets and livestock) . We support POC materials generation, global process development and help to expedite transfer of the process to the CDMO of choice. With a strong team having broad global expertise of pharmaceutical development we can expedite drug development using focused and risk based approaches.

Social media

Skills

  • Antibodies, Development

Additional questions

Interests

Regulatory AffairsPharmaceutical / TherapeuticsOther biologicalsLivestockEnabling technology (assay, delivery, formulation, manufacturing, ...)Companion animalsAgro-Food Tech

What is your primary goal for attending this event?

Seeking investment opportunitiesNetworking with industry professionalsExploring potential collaborationsLearning about the latest trends in healthtechUnderstanding regulatory and policy developments